Bajaj Healthcare (BAJAJHCARE) | Financial Analysis & Statements
Bajaj Healthcare Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.5B
Gross Profit
682.5M
45.85%
Operating Income
188.7M
12.68%
Net Income
118.3M
7.95%
EPS (Diluted)
₹3.64
Balance Sheet Metrics
Total Assets
8.3B
Total Liabilities
3.7B
Shareholders Equity
4.7B
Debt to Equity
0.79
Cash Flow Metrics
Operating Cash Flow
7.5M
Free Cash Flow
5.0M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Bajaj Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.4B | 4.7B | 6.5B | 6.8B | 6.6B |
| Cost of Goods Sold | 3.1B | 2.6B | 3.9B | 5.0B | 4.6B |
| Gross Profit | 2.3B | 2.1B | 2.6B | 1.8B | 1.9B |
| Gross Margin % | 42.6% | 45.3% | 40.1% | 27.0% | 29.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 205.4M | 154.1M | 214.0M | 70.7M | 61.4M |
| Other Operating Expenses | 483.1M | 558.7M | 615.9M | 136.9M | 137.7M |
| Total Operating Expenses | 688.5M | 712.7M | 829.9M | 207.6M | 199.1M |
| Operating Income | 549.9M | 487.1M | 943.1M | 1.0B | 1.2B |
| Operating Margin % | 10.1% | 10.3% | 14.6% | 15.3% | 18.5% |
| Non-Operating Items | |||||
| Interest Income | 5.1M | 3.3M | 4.3M | 1.7M | 1.7M |
| Interest Expense | 251.2M | 290.5M | 164.0M | 110.0M | 83.4M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 460.1M | -166.8M | 781.8M | 896.8M | 1.2B |
| Income Tax | 30.8M | -23.5M | 146.5M | 183.0M | 357.1M |
| Effective Tax Rate % | 6.7% | 0.0% | 18.7% | 20.4% | 30.1% |
| Net Income | 395.0M | -837.9M | 430.2M | 713.9M | 831.1M |
| Net Margin % | 7.3% | -17.7% | 6.7% | 10.5% | 12.7% |
| Key Metrics | |||||
| EBITDA | 967.5M | 817.9M | 1.2B | 1.2B | 1.4B |
| EPS (Basic) | ₹13.29 | ₹-30.36 | ₹15.59 | ₹25.87 | ₹30.11 |
| EPS (Diluted) | ₹13.12 | ₹-30.36 | ₹15.59 | ₹25.87 | ₹30.11 |
| Basic Shares Outstanding | 29716376 | 27598400 | 27598400 | 27598400 | 27598400 |
| Diluted Shares Outstanding | 29716376 | 27598400 | 27598400 | 27598400 | 27598400 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Bajaj Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 26.0M | 21.7M | 177.2M | 19.8M | 142.4M |
| Short-term Investments | 18.5M | 7.5M | 15.1M | 110.2M | 6.6M |
| Accounts Receivable | 2.5B | 1.8B | 1.9B | 1.8B | 988.8M |
| Inventory | 1.6B | 1.4B | 2.1B | 1.6B | 971.1M |
| Other Current Assets | 339.6M | 423.1M | 512.2M | 1.0K | 474.4M |
| Total Current Assets | 5.6B | 4.7B | 5.0B | 4.0B | 2.6B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.4B | 10.3M | 10.3M | 44.3M | 44.3M |
| Goodwill | 14.0M | 18.1M | 13.9M | 0 | - |
| Intangible Assets | 14.0M | 18.1M | 13.9M | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -1.0K | 1.0K | -2.4M | 1.0K | -1.0K |
| Total Non-Current Assets | 2.7B | 2.9B | 4.0B | 3.2B | 2.7B |
| Total Assets | 8.3B | 7.6B | 9.0B | 7.2B | 5.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 954.7M | 894.3M | 847.5M | 1.0B | 689.5M |
| Short-term Debt | 1.6B | 2.9B | 3.2B | 1.9B | 1.0B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 70.7M | 300.0K | 300.0K | 11.7M | 14.9M |
| Total Current Liabilities | 3.0B | 4.4B | 4.3B | 3.2B | 1.8B |
| Non-Current Liabilities | |||||
| Long-term Debt | 649.2M | 391.5M | 944.2M | 663.1M | 797.1M |
| Deferred Tax Liabilities | - | 0 | 5.0M | 15.6M | 21.5M |
| Other Non-Current Liabilities | -2.0K | - | -1.0K | - | -1.0K |
| Total Non-Current Liabilities | 699.0M | 452.9M | 963.7M | 705.4M | 846.5M |
| Total Liabilities | 3.7B | 4.9B | 5.3B | 3.9B | 2.7B |
| Equity | |||||
| Common Stock | 157.9M | 138.0M | 138.0M | 138.0M | 138.0M |
| Retained Earnings | 3.0B | 2.7B | 3.5B | 3.2B | 2.5B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.7B | 2.8B | 3.7B | 3.3B | 2.6B |
| Key Metrics | |||||
| Total Debt | 2.2B | 3.3B | 4.2B | 2.6B | 1.8B |
| Working Capital | 2.6B | 286.2M | 668.0M | 762.4M | 757.6M |
Balance Sheet Composition
Bajaj Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 420.0M | -1.0B | 582.2M | 896.8M | 1.2B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -622.1M | 385.1M | -1.2B | -1.1B | -640.9M |
| Operating Cash Flow | 13.9M | 205.2M | -439.1M | -87.0M | 628.6M |
| Investing Activities | |||||
| Capital Expenditures | -114.3M | -190.4M | -930.7M | -741.9M | -1.1B |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -38.9M | - | - | - | - |
| Investment Sales | - | 67.2M | 0 | 0 | 50.0M |
| Investing Cash Flow | -164.1M | -115.6M | -936.6M | -749.7M | -1.1B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -27.6M | -27.6M | -41.4M | -13.8M | -24.1M |
| Debt Issuance | 450.0M | - | - | - | - |
| Debt Repayment | -189.1M | - | - | - | - |
| Financing Cash Flow | 216.6M | -359.2M | 1.1B | 863.5M | 280.2M |
| Free Cash Flow | 100.8M | 620.1M | -1.2B | -786.2M | -702.3M |
| Net Change in Cash | 66.4M | -269.7M | -275.4M | 26.8M | -182.3M |
Cash Flow Trend
Bajaj Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.59
Price to Book
2.15
Price to Sales
1.83
PEG Ratio
0.43
Profitability Ratios
Profit Margin
8.13%
Operating Margin
14.56%
Return on Equity
8.47%
Return on Assets
4.74%
Financial Health
Current Ratio
1.89
Debt to Equity
48.93
Beta
0.24
Per Share Data
EPS (TTM)
₹16.16
Book Value per Share
₹154.55
Revenue per Share
₹193.88
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BAJAJHCARE | 10.9B | 20.59 | 2.15 | 8.47% | 8.13% | 48.93 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





